Automated bioprinting solution for high-content screening with the BAB400 bioprinter for optimised 3D tissue and organoid workflow.

• Develop new drug targets
• Improved viability of 3D cell cultures
• Enhanced flexibility with integrated workflows

Consistently dispense, place, and print organoids for use in drug discovery with higher throughput vs. manual workflows. Test drug toxicity or efficacy on 3D models that are representative of native human tissues.

The reliability and reproducibility of BAB allows for consistency in maintaining improved viability of organoids over time.

BAB seamlessly integrates with high-content imagers for monitoring cell health or improved efficiency in end point assays.